Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Weightlifting's risky new trend: a case series of 41 insulin users.

Ip EJ, Barnett MJ, Tenerowicz MJ, Perry PJ.

Curr Sports Med Rep. 2012 Jul-Aug;11(4):176-9. doi: 10.1249/JSR.0b013e31825da97f.

PMID:
22777326
[PubMed - indexed for MEDLINE]
2.

The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.

Ip EJ, Barnett MJ, Tenerowicz MJ, Perry PJ.

Pharmacotherapy. 2011 Aug;31(8):757-66. doi: 10.1592/phco.31.8.757.

PMID:
21923602
[PubMed - indexed for MEDLINE]
3.

Anabolic steroid use in weightlifters and bodybuilders: an internet survey of drug utilization.

Perry PJ, Lund BC, Deninger MJ, Kutscher EC, Schneider J.

Clin J Sport Med. 2005 Sep;15(5):326-30.

PMID:
16162991
[PubMed - indexed for MEDLINE]
4.

Increased premature mortality of competitive powerlifters suspected to have used anabolic agents.

Pärssinen M, Kujala U, Vartiainen E, Sarna S, Seppälä T.

Int J Sports Med. 2000 Apr;21(3):225-7.

PMID:
10834358
[PubMed - indexed for MEDLINE]
5.

The adverse health consequences of the use of multiple performance-enhancing substances--a deadly cocktail.

Perera NJ, Steinbeck KS, Shackel N.

J Clin Endocrinol Metab. 2013 Dec;98(12):4613-8. doi: 10.1210/jc.2013-2310. Epub 2013 Nov 11.

PMID:
24217902
[PubMed - indexed for MEDLINE]
6.

Illicit anabolic steroid use in athletes. A case series analysis.

Perry PJ, Andersen KH, Yates WR.

Am J Sports Med. 1990 Jul-Aug;18(4):422-8.

PMID:
2403192
[PubMed - indexed for MEDLINE]
7.

[Sports, use of performance enhancing drugs and addiction. A conceptual and epidemiological review].

Franques P, Auriacombe M, Tignol J.

Ann Med Interne (Paris). 2001 Nov;152 Suppl 7:37-49. Review. French.

PMID:
11965097
[PubMed - indexed for MEDLINE]
8.

Position stand on androgen and human growth hormone use.

Hoffman JR, Kraemer WJ, Bhasin S, Storer T, Ratamess NA, Haff GG, Willoughby DS, Rogol AD.

J Strength Cond Res. 2009 Aug;23(5 Suppl):S1-S59. doi: 10.1519/JSC.0b013e31819df2e6. Review. Erratum in: J Strength Cond Res. 2010 Feb;24(2):585.

PMID:
19620932
[PubMed - indexed for MEDLINE]
9.

Characteristics and Behaviors of Older Male Anabolic Steroid Users.

Ip EJ, Trinh K, Tenerowicz MJ, Pal J, Lindfelt TA, Perry PJ.

J Pharm Pract. 2014 Mar 18. [Epub ahead of print]

PMID:
24643452
[PubMed - as supplied by publisher]
10.

Psychological and Physical Impact of Anabolic-Androgenic Steroid Dependence.

Ip EJ, Lu DH, Barnett MJ, Tenerowicz MJ, Vo JC, Perry PJ.

Pharmacotherapy. 2012 Sep 11. doi: 10.1002/phar.1123. [Epub ahead of print]

PMID:
22969009
[PubMed - as supplied by publisher]
11.

Anabolic androgenic steroids: a survey of 500 users.

Parkinson AB, Evans NA.

Med Sci Sports Exerc. 2006 Apr;38(4):644-51.

PMID:
16679978
[PubMed - indexed for MEDLINE]
12.

Anabolic steroids: a review for the clinician.

Kutscher EC, Lund BC, Perry PJ.

Sports Med. 2002;32(5):285-96. Review.

PMID:
11929356
[PubMed - indexed for MEDLINE]
13.

Performance-enhancing substance misuse in sport: risk factors and considerations for success and failure in intervention programs.

Bahrke MS.

Subst Use Misuse. 2012 Nov-Dec;47(13-14):1505-16. doi: 10.3109/10826084.2012.705674. Review.

PMID:
23186455
[PubMed - indexed for MEDLINE]
14.

New onset diabetes associated with bovine growth hormone and testosterone abuse in a young body builder.

Geraci MJ, Cole M, Davis P.

Hum Exp Toxicol. 2011 Dec;30(12):2007-12. doi: 10.1177/0960327111408152. Epub 2011 May 9.

PMID:
21558143
[PubMed - indexed for MEDLINE]
15.

Performance enhancing drugs (doping agents) and sudden death--a case report and review of the literature.

Hausmann R, Hammer S, Betz P.

Int J Legal Med. 1998;111(5):261-4. Review.

PMID:
9728754
[PubMed - indexed for MEDLINE]
16.

Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.

Striegel H, Simon P, Frisch S, Roecker K, Dietz K, Dickhuth HH, Ulrich R.

Drug Alcohol Depend. 2006 Jan 4;81(1):11-9. Epub 2005 Jul 11.

PMID:
16009506
[PubMed - indexed for MEDLINE]
17.

Vertebral artery dissection in weightlifter with performance enhancing drug use.

Low A, Dovey J, Ash-Miles J.

BMJ Case Rep. 2011 Nov 8;2011. pii: bcr0920114768. doi: 10.1136/bcr.09.2011.4768.

PMID:
22674112
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Social psychological determinants of the use of performance-enhancing drugs by gym users.

Wiefferink CH, Detmar SB, Coumans B, Vogels T, Paulussen TG.

Health Educ Res. 2008 Feb;23(1):70-80. Epub 2007 Feb 13.

PMID:
17301058
[PubMed - indexed for MEDLINE]
Free Article
19.

[Control of doping. That is relevant for more than Olympic competitors].

Bischoff M.

MMW Fortschr Med. 2012 Jul 26;154(13):23. German. No abstract available.

PMID:
22957374
[PubMed - indexed for MEDLINE]
20.

Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.

Larance B, Degenhardt L, Copeland J, Dillon P.

Drug Alcohol Rev. 2008 Nov;27(6):679-86. doi: 10.1080/09595230802392568.

PMID:
18825549
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk